Quarterly report · Q1

Period2024-01-01 → 2024-03-31
Filed2024-05-15
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥5.9bn2024-01-01 → 2024-03-31Cons.Revenue IFRS
Revenue¥26.0bn2023-01-01 → 2023-12-31Cons.Revenue IFRS (5-year summary)
Revenue¥4.2bn2023-01-01 → 2023-03-31Cons.Revenue IFRS
Operating income¥2.3bn2024-01-01 → 2024-03-31Cons.Operating profit loss IFRS
Operating income¥398m2023-01-01 → 2023-03-31Cons.Operating profit loss IFRS
Profit before tax¥1.8bn2024-01-01 → 2024-03-31Cons.Profit loss before tax IFRS
Profit before tax¥12.6bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥65m2023-01-01 → 2023-03-31Cons.Profit loss before tax IFRS
Net income (owners)¥1.5bn2024-01-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥8.1bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥3m2023-01-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS
Net income¥1.3bn2024-01-01 → 2024-03-31Cons.Profit loss IFRS
Net income¥9.5bn2023-01-01 → 2023-12-31Cons.Profit loss IFRS (5-year summary)
Net income−¥342m2023-01-01 → 2023-03-31Cons.Profit loss IFRS
Total assets¥65.6bnat 2024-03-31Cons.Assets IFRS
Total assets¥62.4bnat 2023-12-31Cons.Assets IFRS
Total assets¥34.1bnat 2023-03-31Cons.Total assets IFRS (5-year summary)
Total liabilities¥27.8bnat 2024-03-31Cons.Liabilities IFRS
Total liabilities¥26.3bnat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥37.8bnat 2024-03-31Cons.Equity IFRS
Net assets / equity¥36.1bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥19.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥19.8bnat 2022-12-31dCons.Equity IFRS
Equity (owners)¥34.6bnat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥33.8bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥21.2bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥20.3bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥21.6bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥10.6bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥11.0bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Operating cash flow−¥350m2024-01-01 → 2024-03-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥6.5bn2023-01-01 → 2023-12-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥710m2023-01-01 → 2023-03-31Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥1.8bn2024-01-01 → 2024-03-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥6.8bn2023-01-01 → 2023-12-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥1.2bn2023-01-01 → 2023-03-31Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥88m2024-01-01 → 2024-03-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥10.7bn2023-01-01 → 2023-12-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥52m2023-01-01 → 2023-03-31Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥29.172024-01-01 → 2024-03-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥169.52023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-0.062023-01-01 → 2023-03-31Cons.Basic earnings loss per share IFRS
EPS (diluted)¥282024-01-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥165.562023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-0.062023-01-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS
Equity ratio52.7%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio54.2%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio62.2%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 22
SegmentItemPeriodValue
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue2024-01-01 → 2024-03-31¥1.3bn
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue external2024-01-01 → 2024-03-31¥1.3bn
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentsegment profit2024-01-01 → 2024-03-31¥539m
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentrevenue2024-01-01 → 2024-03-31¥4.6bn
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentrevenue external2024-01-01 → 2024-03-31¥4.6bn
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentsegment profit2024-01-01 → 2024-03-31¥1.7bn
—segment totalrevenue2024-01-01 → 2024-03-31¥5.9bn
—segment totalrevenue external2024-01-01 → 2024-03-31¥5.9bn
—segment totalsegment profit2024-01-01 → 2024-03-31¥2.3bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-03-31−¥23m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-03-31−¥23m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue2023-01-01 → 2023-03-31¥623m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue external2023-01-01 → 2023-03-31¥600m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentrevenue intersegment2023-01-01 → 2023-03-31¥23m
jpcrp040300-q1r_E05712-000Medical Devicereportable segmentsegment profit2023-01-01 → 2023-03-31¥248m
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentrevenue2023-01-01 → 2023-03-31¥3.6bn
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentrevenue external2023-01-01 → 2023-03-31¥3.6bn
jpcrp040300-q1r_E05712-000Pharmaceuticalreportable segmentsegment profit2023-01-01 → 2023-03-31¥149m
—segment totalrevenue2023-01-01 → 2023-03-31¥4.2bn
—segment totalrevenue external2023-01-01 → 2023-03-31¥4.2bn
—segment totalrevenue intersegment2023-01-01 → 2023-03-31¥23m
—segment totalsegment profit2023-01-01 → 2023-03-31¥398m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 599
ItemContextValueUnit
Comprehensive income attributable to non controlling interests IFRSCurrentYTDDuration16340000JPY
Equity IFRSPrior2YearInstant_ShareCapitalIFRSMember10893070000JPY
Equity IFRSPrior2YearInstant_CapitalSurplusIFRSMember6233386000JPY
Equity IFRSPrior2YearInstant_TreasurySharesIFRSMember-756000JPY
Equity IFRSPrior2YearInstant_RetainedEarningsIFRSMember696360000JPY
Equity IFRSPrior2YearInstant_ShareAcquisitionRightsIFRSMember824192000JPY
Equity IFRSPrior2YearInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember2323439000JPY
Equity IFRSPrior2YearInstant_OtherComponentsOfEquityIFRSMember3147631000JPY
Profit loss IFRSPrior1YTDDuration_ShareCapitalIFRSMember-JPY
Profit loss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-JPY
Profit loss IFRSPrior1YTDDuration_TreasurySharesIFRSMember-JPY
Profit loss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-2874000JPY
Profit loss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember-JPY
Profit loss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Profit loss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember-JPY
Other comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember-JPY
Other comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-JPY
Other comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember-JPY
Other comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-JPY
Other comprehensive income IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember-JPY
Other comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember206546000JPY
Other comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember206546000JPY
Comprehensive income IFRSPrior1YTDDuration_ShareCapitalIFRSMember-JPY
Comprehensive income IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-JPY
Comprehensive income IFRSPrior1YTDDuration_TreasurySharesIFRSMember-JPY
Comprehensive income IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-2874000JPY
Comprehensive income IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember-JPY
Comprehensive income IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember206546000JPY
Comprehensive income IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember206546000JPY
Issuance of new shares ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember1837000JPY
Issuance of new shares ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember1837000JPY
Issuance of new shares ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember-JPY
Issuance of new shares ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-JPY
Issuance of new shares ss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember-JPY
Issuance of new shares ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Issuance of new shares ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember-JPY
Share based payment transactions ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember-JPY
Share based payment transactions ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-JPY
Share based payment transactions ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember-JPY
Share based payment transactions ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-JPY
Share based payment transactions ss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember50245000JPY
Share based payment transactions ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Share based payment transactions ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember50245000JPY
Forfeiture of share acquisition rights ss IFRSPrior1YTDDuration_ShareCapitalIFRSMember-JPY
Forfeiture of share acquisition rights ss IFRSPrior1YTDDuration_CapitalSurplusIFRSMember-JPY
Forfeiture of share acquisition rights ss IFRSPrior1YTDDuration_TreasurySharesIFRSMember-JPY
Forfeiture of share acquisition rights ss IFRSPrior1YTDDuration_RetainedEarningsIFRSMember-JPY
Forfeiture of share acquisition rights ss IFRSPrior1YTDDuration_ShareAcquisitionRightsIFRSMember-21725000JPY
Forfeiture of share acquisition rights ss IFRSPrior1YTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember-JPY
Forfeiture of share acquisition rights ss IFRSPrior1YTDDuration_OtherComponentsOfEquityIFRSMember-21725000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-12-31pass
balance sheet identityconsolidated 2024-03-31pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-03-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-03-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-03-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-03-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-03-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-03-31pass